Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for Tough-to-Treat lung cancer patients

NCT ID NCT06623136

Recruiting now Disease control Sponsor: Elpiscience (Suzhou) Biopharma, Ltd. Source: ClinicalTrials.gov ↗

Summary

This study is testing whether combining two immunotherapy drugs (ES102 and toripalimab) can help control advanced non-small cell lung cancer in patients whose previous treatments have stopped working. The trial will enroll 40 adults with specific types of lung cancer to see how well the combination shrinks tumors and how safe it is. Researchers will measure tumor response, side effects, and how long the treatment keeps the cancer from progressing.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Beijing Chest Hospital, Capital Medical University

    RECRUITING

    Beijing, Beijing Municipality, China

    Contact

    Contact

  • Cancer Hospital of Shandong First Medical University (Shandong Cancer Institute, Shandong Cancer Hospital)

    NOT_YET_RECRUITING

    Jinan, Shandong, China

    Contact

    Contact

  • Henan Cancer Hospital

    RECRUITING

    Zhengzhou, Henan, China

    Contact Phone: •••-•••-••••

    Contact

  • Jilin Cancer Hospital

    RECRUITING

    Changchun, Jilin, China

    Contact

    Contact

  • Shanxi Provincial Cancer Hospital

    RECRUITING

    Taiyuan, China

    Contact

    Contact

  • Taizhou Hospital

    RECRUITING

    Taizhou, China

    Contact

    Contact

  • The First Affiliated Hospital of He'nan University of Science and Technology

    RECRUITING

    Luoyang, China

    Contact

    Contact

  • The First Affiliated Hospital of Nanchang University

    NOT_YET_RECRUITING

    Nanchang, Jiangxi, China

    Contact

    Contact

  • The First Affiliated Hospital of Zhengzhou University

    RECRUITING

    Zhengzhou, Henan, China

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.

NON SMALL CELL LUNG CANCER